Shanghai Sanyou Medical Co Ltd Asset Resilience Ratio

Latest as of September 2025: 7.69%

Shanghai Sanyou Medical Co Ltd asset resilience ratio. Shanghai Sanyou Medical Co Ltd (688085) has an Asset Resilience Ratio of 7.69% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688085 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥180.23 Million
≈ $26.37 Million USD Cash + Short-term Investments

Total Assets

CN¥2.34 Billion
≈ $343.00 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Shanghai Sanyou Medical Co Ltd (2020–2024)

Asset resilience ratio of Shanghai Sanyou Medical Co Ltd from 2020 to 2024. This chart shows how Shanghai Sanyou Medical Co Ltd's Asset Resilience Ratio has changed over time. Read Shanghai Sanyou Medical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Sanyou Medical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 688085 total asset value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥180.23 Million 7.69%
Total Liquid Assets CN¥180.23 Million 7.69%

Asset Resilience Insights

  • Limited Liquidity: Shanghai Sanyou Medical Co Ltd maintains only 7.69% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai Sanyou Medical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shanghai Sanyou Medical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Demant A/S
CO:DEMANT
Medical Devices -2.59%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%
Imricor Medical Systems Inc
AU:IMR
Medical Devices 46.50%

Shanghai Sanyou Medical Co Ltd Asset Resilience Ratio by Year (2020–2024)

Shanghai Sanyou Medical Co Ltd asset resilience ratio by year from 2020 to 2024. The table below shows the annual Asset Resilience Ratio data for Shanghai Sanyou Medical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.18% CN¥50.23 Million
≈ $7.35 Million
CN¥2.31 Billion
≈ $337.54 Million
+1.31pp
2023-12-31 0.87% CN¥19.63 Million
≈ $2.87 Million
CN¥2.26 Billion
≈ $330.93 Million
-7.94pp
2022-12-31 8.81% CN¥193.10 Million
≈ $28.26 Million
CN¥2.19 Billion
≈ $320.67 Million
-10.05pp
2021-12-31 18.86% CN¥376.63 Million
≈ $55.11 Million
CN¥2.00 Billion
≈ $292.25 Million
-33.85pp
2020-12-31 52.71% CN¥880.65 Million
≈ $128.87 Million
CN¥1.67 Billion
≈ $244.47 Million
--
pp = percentage points

About Shanghai Sanyou Medical Co Ltd

SHG:688085 China Medical Devices
Market Cap
$620.69 Million
CN¥4.24 Billion CNY
Market Cap Rank
#10816 Global
#2930 in China
Share Price
CN¥12.72
Change (1 day)
-0.55%
52-Week Range
CN¥11.41 - CN¥23.21
All Time High
CN¥70.68
About

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system… Read more